AlphaFold predicted structure
PDE4D · Q08499

Mean pLDDT
67.4/ 100
Low
809 residues
Confidence breakdown
- Very high(≥ 90)38%
- Confident(70–90)14%
- Low(50–70)7%
- Very low(< 50)40%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphodiesterase 4D
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Albright hereditary osteodystrophy, pseudohypoparathyroidism, pseudopseudohypoparathyroidism, acrodysostosis and osteoma cutis
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedacrodysostosis 2 with or without hormone resistance
acrodysostosis
asthma
chronic obstructive pulmonary disease
atopic eczema
Oral ulcer
psoriasis
psoriasis vulgaris
psoriatic arthritis
Airway obstruction
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
3',5'-cyclic-AMP phosphodiesterase 4D
Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes
Curated MONDO disease pages that list PDE4D among their top associated genes.
PDE4D · Q08499

Mean pLDDT
67.4/ 100
Low
809 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0